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ABSTRACT
Women in later stages of pregnancy are at increased risk for serious influenza-related morbid-
ity; thus, universal influenza vaccination of pregnant women is recommended. However, vac-
cine uptake in the United States has been suboptimal. We previously described the burden of
severe influenza-related morbidity during pregnancy in the United States by examining hospi-
talizations of pregnant women with respiratory illness during influenza season. Nondelivery
hospitalizations with respiratory illness had significantly longer lengths of stay than those with-
out respiratory illness. Hospitalization characteristics associated with greater likelihood of res-
piratory illness were the presence of a high-risk condition for which influenza vaccination is rec-
ommended, Medicaid/Medicare as primary expected payer, and hospitalization in a rural area.
These findings may be explained by these women being at higher risk of influenza-related mor-
bidity or reflect disparities in receipt of influenza immunization. Universal vaccination of preg-
nant women to decrease influenza-related morbidity should be encouraged.
891
THE PHYSIOLOGICAL CHANGES that accompanypregnancy may leave women more vulnera-
ble to respiratory disorders. Women in their 
second or third trimester of pregnancy during in-
fluenza season are at increased risk of influenza-
related morbidity in comparison to nonpregnant
and postpartum women.1 Previous studies of in-
fluenza-related morbidity among pregnant wo-
men suggested that 2.5 hospitalizations per 1000
women in the third trimester of pregnancy were
attributable to influenza during average periods
of viral activity.1 The increased risk of influenza-
related morbidity may result from increases in
heart rate, stroke volume, oxygen consumption,
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or decreases in lung capacity and changes in im-
munological function during pregnancy.2 The
Advisory Committee of Immunization Practices
(ACIP) of the Centers for Disease Control and
Prevention (CDC) and the American College of
Obstetrics and Gynecology (ACOG) recommend
influenza vaccination for all women who will be
pregnant during influenza season3,4; in practice,
however, vaccination rates among pregnant wo-
men are low.3,5
We previously described the burden that in-
fluenza places on inpatient healthcare of preg-
nant women.6 Hospital discharge data were ob-
tained from the Healthcare Cost and Utilization
Project (HCUP), Nationwide Inpatient Sample
(NIS). The NIS is a research database produced
annually through a partnership between the
Agency for Healthcare Research and Quality
(AHRQ) and public and private statewide data
organizations to provide national estimates of in-
patient care delivered in the United States.7 It is
the largest collection of all-payer inpatient care
data in the United States and provides patient de-
mographic and diagnostic/procedural data as
well as facility information.
Contrary to all hospitalizations of pregnant wo-
men, the majority of hospitalizations with 
respiratory illness among pregnant women dur-
ing influenza season did not include a delivery.
During the four influenza seasons examined
(1998–1999 through 2001–2002), there were 21,447
pregnancy hospitalizations with a diagnosis of
respiratory illness, 70% of which did not include
the delivery of a liveborn infant (n  15,047).6 This
contrasts with overall hospitalizations among
pregnant women, of which 88% are for delivery.8
During influenza season, nondelivery hospi-
talizations with respiratory illness among preg-
nant women are a significant source of maternal
morbidity and are associated with increased
health services utilization. The proportion of non-
delivery hospitalizations with a diagnosis of res-
piratory illness increased substantially during pe-
riods of viral activity (Fig. 1). The proportion of
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FIG. 1. Proportion of nondelivery hospitalizations with respiratory illness, by presence of high-risk condition,
1998–2002. High-risk hospitalizations include a diagnosis for a high-risk condition for which influenza vaccination is
recommended by the Advisory Committee on Immunization Practices (chronic cardiac disease, chronic pulmonary
disease, diabetes mellitus, chronic renal disease, malignancies, and immunosuppressive disorders). Influenza months
are months in which 5% of specimens sampled by the World Health Organization (WHO) and National Respira-
tory and Enteric Virus Surveillance System (NRVESS) Collaborating Laboratories tested positive for an influenza iso-
late. For each influenza season, the predominant viral strain is indicated as H1N1 or H3N2 for influenza A isolates
and B for influenza B isolates.
nondelivery hospitalizations with respiratory ill-
ness was 22.3/1000 during influenza season and
11.7/1000 during the rest of the year.6 During in-
fluenza season, mean length of stay was signifi-
cantly longer for nondelivery hospitalizations
with respiratory illness than for nondelivery hos-
pitalizations without respiratory illness (3.88
days vs. 2.65 days, p  0.001).6
Influenza vaccination is the primary method
for preventing influenza-related morbidity.
Hospitalization characteristics found to be as-
sociated with increased odds of respiratory ill-
ness may be reflective of disparities in influenza
immunization or limited uptake by pregnant
women at high risk (or both). Hospitalizations
in rural locations and with intended payer of
public origin (Medicaid/Medicare) were asso-
ciated with increased odds of respiratory hos-
pitalization during influenza season.6 Non-
whites, rural residents, and lower-income
groups are less likely to be immunized than
comparison groups, and persons who received
the influenza vaccine are most likely to receive
it at a private medical clinic.5 The presence of a
condition for which CDC guidelines specifically
recommend influenza vaccination increased the
odds of having respiratory illness 3-fold among
nondelivery hospitalizations.6 Rates of serious
illness are higher among persons with high-risk
medical conditions; still, current data suggest
that vaccination rates among persons with high-
risk medical conditions are low.3,5
Programs that aim to decrease morbidity
from influenza-associated illness among preg-
nant women should include interventions to im-
prove influenza vaccine availability and use for
both healthy pregnant women and pregnant
women at high risk.9 Universal vaccination with
inactivated trivalent influenza vaccine is cost-
effective compared with supportive care of in-
fluenza-related illness in the pregnant popula-
tion.10 Researchers, healthcare providers, and
policymakers can use these data to develop
strategies for reducing influenza-associated
morbidity in pregnant women, specifically by
promoting universal influenza immunization
during pregnancy. 
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